ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.59
1.05%
US Tech 100
20,332.80
1.61%
S&P 500
5,954.50
1.59%
US Dollar vs CAD
1.44675
0.00%
Bitcoin
85,416.34
1.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lisata Therapeutics Inc (LSTA)

  7. Lisata Therapeutics Inc (LSTA) News

LSTA

Lisata Therapeutics (LSTA)

Lisata Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LSTA
DateTimeSourceHeadlineSymbolCompany
02/27/20253:05PMGlobeNewswire Inc.Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
02/20/20257:00AMGlobeNewswire Inc.Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025NASDAQ:LSTALisata Therapeutics Inc
02/05/20257:30AMGlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 BIO CEO & Investor ConferenceNASDAQ:LSTALisata Therapeutics Inc
01/23/20257:00AMGlobeNewswire Inc.Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
01/22/20257:00AMGlobeNewswire Inc.Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
01/15/20257:30AMGlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 Sequire Investor SummitNASDAQ:LSTALisata Therapeutics Inc
12/10/20247:30AMGlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
12/03/20247:30AMGlobeNewswire Inc.Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor ImagingNASDAQ:LSTALisata Therapeutics Inc
11/19/20247:30AMGlobeNewswire Inc.Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’NASDAQ:LSTALisata Therapeutics Inc
11/12/20243:05PMGlobeNewswire Inc.Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
11/06/20248:23AMGlobeNewswire Inc.Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research CollaborationNASDAQ:LSTALisata Therapeutics Inc
11/06/20247:30AMGlobeNewswire Inc.Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024NASDAQ:LSTALisata Therapeutics Inc
10/31/20247:30AMGlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
10/28/20247:30AMGlobeNewswire Inc.Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of EndometriosisNASDAQ:LSTALisata Therapeutics Inc
10/03/20247:00AMGlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
09/17/20247:00AMGlobeNewswire Inc.Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER TrialNASDAQ:LSTALisata Therapeutics Inc
09/09/20247:00AMGlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
09/05/20247:00AMGlobeNewswire Inc.Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
08/12/20243:05PMGlobeNewswire Inc.Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
08/05/20247:00AMGlobeNewswire Inc.Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024NASDAQ:LSTALisata Therapeutics Inc
07/18/20247:00AMGlobeNewswire Inc.Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer TherapyNASDAQ:LSTALisata Therapeutics Inc
07/16/20247:00AMGlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
07/10/20247:00AMGlobeNewswire Inc.Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical ModelNASDAQ:LSTALisata Therapeutics Inc
06/13/20247:30AMGlobeNewswire Inc.Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
05/28/20247:30AMGlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
05/20/20247:30AMGlobeNewswire Inc.Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic CancerNASDAQ:LSTALisata Therapeutics Inc
05/09/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LSTALisata Therapeutics Inc
05/09/20243:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LSTALisata Therapeutics Inc
05/09/20243:05PMGlobeNewswire Inc.Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
05/08/20247:00AMGlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LSTA

Your Recent History

USOTC
MONI
Moon Equity (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
SPZI
Spooz (PK)
USOTC
GDVM
Global Developments (PK)
NASDAQ
ILLR
Triller
NASDAQ
LWLG
Lightwave Logic
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
NVDA
NVIDIA
NASDAQ
NB
NioCorp Developments
USOTC
CBRF
CyberFuels (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
XERI
Xeriant (QB)
USOTC
TPTW
TPT Global Tech (PK)
NYSE
AMC
AMC Entertainment
USOTC
WDLF
Decentral Life (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads